跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
黃 俊仁
教授
,
臨床醫學研究所
合聘教授
,
麻醉學科
主治醫師
,
臺北市立萬芳醫院
成員
,
臺北醫學大學細胞治療與再生醫學研究中心
https://orcid.org/0000-0002-1006-6762
電子郵件
huangcj1112
gmail
com
h-index
3814
引文
29
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1999
2024
每年研究成果
概覽
指紋
網路
專案
(15)
研究成果
(153)
資料集
(2)
類似的個人檔案
(6)
指紋
查看啟用 Chun-Jen Huang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Lipopolysaccharide
100%
Endotoxin
47%
Nuclear Factor
36%
Ischemia
31%
Alternative Complement Pathway C3 C5 Convertase
30%
Inducible Nitric Oxide Synthase
29%
Inflammation
28%
Amino Acid Transporter
27%
Nitric Oxide
27%
Heme Oxygenase 1
26%
Hemorrhagic Shock
26%
Magnesium Sulfate
23%
Dexmedetomidine
23%
Acute Lung Injury
22%
Sepsis
19%
Mouse
19%
Cytokine
19%
Endotoxemia
18%
Anti-Inflammation
17%
Cohort Study
17%
Hemin
14%
Tumor Necrosis Factor
14%
Liver Injury
14%
Leg Ischemia
14%
Phosphatidylinositol 3 Kinase
13%
Mitogen Activated Protein Kinase
13%
Vasopressin
13%
Cepharanthine
13%
Ketamine
13%
Arginine
12%
Prostaglandin E2
12%
Antiinflammatory Activity
11%
Interleukin 1
11%
Therapeutic Effect
11%
Testis Torsion
10%
Inflammasome
10%
Receptor Protein
9%
Clonidine
9%
Naloxone
9%
Lidocaine
9%
Levobupivacaine
9%
Synapsin II
9%
Ischemic Heart Disease
9%
Calcium Channel L Type
9%
Interleukin 6
9%
Guanosine Triphosphate Cyclohydrolase I
9%
Malonaldehyde
8%
Isoenzyme
8%
Sodium Chloride
8%
Injury
8%
Medicine and Dentistry
Lipopolysaccharide
40%
Cohort Analysis
20%
Cesarean Section
19%
Meta-Analysis
19%
Systematic Review
16%
Dexmedetomidine
16%
Hemorrhagic Shock
16%
General Anesthesia
14%
Ischemic Heart Disease
13%
Resuscitation
13%
Nitric Oxide
11%
Nuclear Factor
11%
Inducible Nitric Oxide Synthase
11%
Pediatrics
10%
Magnesium Sulfate
10%
Ischemia
10%
Antiinflammatory Activity
10%
Mesenchymal Stem Cell
9%
Ketamine
9%
Macrophage
9%
Alternative Complement Pathway C3 C5 Convertase
9%
Liver Injury
8%
Lipid Diet
7%
Spinal Anaesthesia
7%
Randomized Controlled Trial
7%
Amino Acid Transporter
7%
Acute Lung Injury
7%
Lower Limb
6%
Odds Ratio
6%
Hyperlipidemia
6%
Hazard Ratio
6%
Endotoxin
6%
Signal Transduction
6%
Postoperative Analgesia
6%
Fibromyalgia
6%
Propofol
6%
Placenta
6%
Zusanli
6%
L-Type Calcium Channel
6%
Auriculotherapy
6%
Epidural Analgesia
6%
Exosome
6%
Guanosine Triphosphate Cyclohydrolase I
6%
Therapy Effect
6%
Upregulation
6%
Infusion
5%
Neuraxial Anesthesia
5%
Emergence Delirium
5%
Sodium Chloride
5%
Logistic Regression Analysis
5%
